Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
J Pineal Res
; 60(1): 27-38, 2016 Jan.
Article
in En
| MEDLINE
| ID: mdl-26445000
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
NF-kappa B
/
Drug Resistance, Neoplasm
/
Carcinoma, Pancreatic Ductal
/
Deoxycytidine
/
Melatonin
/
Neoplasm Proteins
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Pineal Res
Journal subject:
ENDOCRINOLOGIA
Year:
2016
Type:
Article
Affiliation country:
China